Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 1
1954 2
1955 1
1957 1
1958 1
1959 1
1960 2
1961 1
1962 2
1963 8
1964 4
1965 3
1967 2
1970 1
1973 2
1976 1
1977 1
1978 1
1979 2
1980 2
1981 2
1982 1
1983 6
1984 3
1985 2
1986 6
1987 12
1988 10
1989 7
1990 9
1991 6
1992 6
1993 9
1994 11
1995 24
1996 19
1997 14
1998 18
1999 10
2000 19
2001 21
2002 19
2003 24
2004 22
2005 38
2006 45
2007 54
2008 50
2009 63
2010 75
2011 91
2012 115
2013 101
2014 118
2015 131
2016 123
2017 145
2018 192
2019 182
2020 221
2021 250
2022 259
2023 32
Text availability
Article attribute
Article type
Publication date

Search Results

2,349 results
Results by year
Filters applied: . Clear all
Page 1
EGFR activation limits the response of liver cancer to lenvatinib.
Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, Wang L, Wang S, Wang C, Dias MH, Jochems F, Yang Y, Bosma A, Hijmans EM, de Groot MHP, Vegna S, Cui D, Zhou Y, Ling J, Wang H, Guo Y, Zheng X, Isima N, Wu H, Sun C, Beijersbergen RL, Akkari L, Zhou W, Zhai B, Qin W, Bernards R. Jin H, et al. Among authors: ling j. Nature. 2021 Jul;595(7869):730-734. doi: 10.1038/s41586-021-03741-7. Epub 2021 Jul 21. Nature. 2021. PMID: 34290403
Inflammasomes in Alveolar Bone Loss.
Li Y, Ling J, Jiang Q. Li Y, et al. Among authors: ling j. Front Immunol. 2021 Jun 9;12:691013. doi: 10.3389/fimmu.2021.691013. eCollection 2021. Front Immunol. 2021. PMID: 34177950 Free PMC article. Review.
Mapping the genetic landscape of DNA double-strand break repair.
Hussmann JA, Ling J, Ravisankar P, Yan J, Cirincione A, Xu A, Simpson D, Yang D, Bothmer A, Cotta-Ramusino C, Weissman JS, Adamson B. Hussmann JA, et al. Among authors: ling j. Cell. 2021 Oct 28;184(22):5653-5669.e25. doi: 10.1016/j.cell.2021.10.002. Epub 2021 Oct 20. Cell. 2021. PMID: 34672952 Free PMC article.
Expert consensus on dental caries management.
Cheng L, Zhang L, Yue L, Ling J, Fan M, Yang D, Huang Z, Niu Y, Liu J, Zhao J, Li Y, Guo B, Chen Z, Zhou X. Cheng L, et al. Among authors: ling j. Int J Oral Sci. 2022 Mar 31;14(1):17. doi: 10.1038/s41368-022-00167-3. Int J Oral Sci. 2022. PMID: 35361749 Free PMC article. Review.
A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes.
Bousbaine D, Fisch LI, London M, Bhagchandani P, Rezende de Castro TB, Mimee M, Olesen S, Reis BS, VanInsberghe D, Bortolatto J, Poyet M, Cheloha RW, Sidney J, Ling J, Gupta A, Lu TK, Sette A, Alm EJ, Moon JJ, Victora GD, Mucida D, Ploegh HL, Bilate AM. Bousbaine D, et al. Among authors: ling j. Science. 2022 Aug 5;377(6606):660-666. doi: 10.1126/science.abg5645. Epub 2022 Aug 4. Science. 2022. PMID: 35926021 Free PMC article.
MEF2C promotes M1 macrophage polarization and Th1 responses.
Zhao X, Di Q, Liu H, Quan J, Ling J, Zhao Z, Xiao Y, Wu H, Wu Z, Song W, An H, Chen W. Zhao X, et al. Among authors: ling j. Cell Mol Immunol. 2022 Apr;19(4):540-553. doi: 10.1038/s41423-022-00841-w. Epub 2022 Feb 22. Cell Mol Immunol. 2022. PMID: 35194174
Clinical targeting of HIV capsid protein with a long-acting small molecule.
Link JO, Rhee MS, Tse WC, Zheng J, Somoza JR, Rowe W, Begley R, Chiu A, Mulato A, Hansen D, Singer E, Tsai LK, Bam RA, Chou CH, Canales E, Brizgys G, Zhang JR, Li J, Graupe M, Morganelli P, Liu Q, Wu Q, Halcomb RL, Saito RD, Schroeder SD, Lazerwith SE, Bondy S, Jin D, Hung M, Novikov N, Liu X, Villaseñor AG, Cannizzaro CE, Hu EY, Anderson RL, Appleby TC, Lu B, Mwangi J, Liclican A, Niedziela-Majka A, Papalia GA, Wong MH, Leavitt SA, Xu Y, Koditek D, Stepan GJ, Yu H, Pagratis N, Clancy S, Ahmadyar S, Cai TZ, Sellers S, Wolckenhauer SA, Ling J, Callebaut C, Margot N, Ram RR, Liu YP, Hyland R, Sinclair GI, Ruane PJ, Crofoot GE, McDonald CK, Brainard DM, Lad L, Swaminathan S, Sundquist WI, Sakowicz R, Chester AE, Lee WE, Daar ES, Yant SR, Cihlar T. Link JO, et al. Among authors: ling j. Nature. 2020 Aug;584(7822):614-618. doi: 10.1038/s41586-020-2443-1. Epub 2020 Jul 1. Nature. 2020. PMID: 32612233 Free PMC article. Clinical Trial.
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
Hu H, Kang L, Zhang J, Wu Z, Wang H, Huang M, Lan P, Wu X, Wang C, Cao W, Hu J, Huang Y, Huang L, Wang H, Shi L, Cai Y, Shen C, Ling J, Xie X, Cai Y, He X, Dou R, Zhou J, Ma T, Zhang X, Luo S, Deng W, Ling L, Liu H, Deng Y. Hu H, et al. Among authors: ling j. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):38-48. doi: 10.1016/S2468-1253(21)00348-4. Epub 2021 Oct 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34688374 Clinical Trial.
2,349 results